The Boston Globe

Business

Warp Drive Bio launches with initial financing of $125 million

Boston venture capital firm Third Rock Ventures announced the launch of a genomic search engine company in strategic partnership with Sanofi SA, the French drug maker that recently bought Genzyme Corp. of Cambridge for $20.1 billion. The new company --- Warp Drive Bio --- will have $125 million in initial financing. Alexis Borisy, partner at Third Rock Ventures, is the interim chief executive officer of Warp Drive Bio.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

BostonGlobe.comSubscriber Log In

Contact us for help